ATOSSA THERAPEUTICS, INC. cotiza a 2.39 USD y tiene una capitalización bursátil de $24M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clin…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.95 | $-1.11 | $-1.34 | $-1.05 |
| Estimado | $-1.10 | $-0.99 | $-1.14 | $-1.00 |
| Sorpresa | +13.6% | -12.1% | -17.5% | -5.0% |
| Métrica | ATOS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -88.3% | -40.4% | -47.9% |
| ROA | -73.0% | -32.0% | -41.0% |
| Current Ratio | 5.53 | 2.84 | +2.69 |
| Debt / Equity | — | 0.28 | — |